^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ALLO-501

i
Other names: ALLO-501, ALLO 501
Associations
Trials
Company:
Allogene Therap, Cellectis, MaxCyte
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials